Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific : Says 2Q Sales Boosted by Pandemic Response

share with twitter share with LinkedIn share with facebook
07/06/2020 | 08:42am EDT

By Colin Kellaher

 

Thermo Fisher Scientific Inc. Monday said its fiscal second-quarter revenue will exceed expectations, bolstered by sales aimed at supporting the global response to the coronavirus pandemic.

The Waltham, Mass., company said it expects reported and organic revenue growth of about 10% for the quarter ended June 27.

The company in mid-May had said it expected second-quarter organic revenue would be flat to down 10%, but it noted that results could fall outside that range due to uncertainty in the marketplace.

Thermo Fisher Monday said strong global sales of PCR-based tests and other products and services supporting the Covid-19 response contributed more than $1.4 billion of revenue in the second quarter.

Analysts polled by FactSet, on average, were expecting the company to report quarterly sales of $5.82 billion, down from $6.32 billion a year earlier.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

share with twitter share with LinkedIn share with facebook
Latest news on THERMO FISHER SCIENTIFIC
08:23aTHERMO FISHER SCIENTIFIC : Accelerates Nanometer-Scale Research with Next-Genera..
AQ
08:23aTHERMO FISHER SCIENTIFIC : Versatile Thermo Scientific Helios 5 PFIBs Enable Mat..
AQ
08/06Davidson Kempner says again it will not be tendering Qiagen shares
RE
08/06Davidson Kempner says again it will not be tendering Qiagen shares
RE
08/05THERMO FISHER SCIENTIFIC : 's COVID-19 Response Continues to Expand with New Hig..
PR
08/05The Global pH Sensors & Analyzers Market to Garner $1939.5 Million by 2028
AQ
08/04THERMO FISHER SCIENTIFIC INC. : Other Events, Financial Statements and Exhibits ..
AQ
08/04THERMO FISHER SCIENTIFIC : Confirms Offer to Acquire QIAGEN Shares Expires on Au..
PR
08/04THERMO FISHER SCIENTIFIC : OIE Approves Registration of VetMAX African Swine Fev..
AQ
08/03THERMO FISHER SCIENTIFIC : China Approves Thermo Fisher Scientific's African Swi..
PU
More news
Financials (USD)
Sales 2020 28 041 M - -
Net income 2020 4 456 M - -
Net Debt 2020 12 658 M - -
P/E ratio 2020 37,1x
Yield 2020 0,21%
Capitalization 164 B 164 B -
EV / Sales 2020 6,32x
EV / Sales 2021 5,94x
Nbr of Employees 75 000
Free-Float 90,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Average target price 442,72 $
Last Close Price 415,73 $
Spread / Highest target 20,3%
Spread / Average Target 6,49%
Spread / Lowest Target -34,8%
EPS Revisions
Managers
NameTitle
Marc N. Casper Chairman, President & Chief Executive Officer
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Scott M. Sperling Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
THERMO FISHER SCIENTIFIC27.97%164 458
DANAHER CORPORATION34.02%145 918
INTUITIVE SURGICAL, INC.16.93%80 894
ILLUMINA, INC.20.37%58 702
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.84.17%58 573
BOSTON SCIENTIFIC CORPORATION-16.21%54 208